Status:
COMPLETED
Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Duke University
Conditions:
Chronic Illness
Adverse Effects
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if a medication therapy management program designed to reconcile a patient's medications and identify and resolve drug related problems can reduce adverse dru...
Detailed Description
This study will be a multicenter, prospective, randomized study of usual care (Arm 1; control group) compared with usual care plus medication reconciliation by patient interview and a drug related pro...
Eligibility Criteria
Inclusion
- Be at least 65 years old at enrollment
- Primarily uses English language for written and oral communication
- Have three or more comorbid conditions associated with increased healthcare utilization (Diabetes Mellitus, Congestive Heart Failure, Asthma, Hypertension, Dyslipidemia, COPD, Coronary Artery Disease, Chronic Renal Failure, Arthritis, Depression, Dementia, Chronic Pain, Conditions requiring anticoagulation with warfarin)
- Have visited a physician at one or more of the clinics on a regular basis (defined as two or more clinic visits over one year prior to the study start) for these conditions
- Have received 6 or more different chronic prescription medications over the six months prior to the enrollment period
- Have a telephone line and agree to maintain it for at least six months
- Have one of the following situations placing him/her at risk for a DRP (Any ER visit in past 30 days or Urgent Care visit in past 30 days leading to a change in medication or change in medication dose; New physician visit in past 30 days; Hospitalization in past 30 days; Invasive procedure (a procedure requiring substantive changes to medication taking practices or which requires informed consent) in past 30 days; Change in medication in past 30 days; Three or more providers seen in the past year
Exclusion
- Terminal condition, where life expectancy is less than 6 months
- Patients already enrolled in an MTM program where medication reconciliation and/or assessment of DRPs has occurred in the previous 12 months
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
637 Patients enrolled
Trial Details
Trial ID
NCT00773942
Start Date
November 1 2007
End Date
January 1 2010
Last Update
July 24 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60612
2
Duke University Health System
Durham, North Carolina, United States, 27705
3
Baylor Health Care System
Dallas, Texas, United States, 75206